Sign up to save your podcasts
Or
Share Episode 122: predicing dementia, incentives to quit smoking, HP eradication for dyspepsia, and comparison of diabetes meds
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 122: predicing dementia, incentives to quit smoking, HP eradication for dyspepsia, and comparison of diabetes meds
Join Kate, Mark, Gary and Henry as they discuss whether we should (or can) use biomarkers to predict mild cognitive impairment or dementia, financial incentives to promote smoking cessation, the efficacy of HP eradication for functional dyspepsia, and results of the glycemic control arm of the GRADE Trial.
View all episodes
By Mark Ebell
4.7
9292 ratings
Join Kate, Mark, Gary and Henry as they discuss whether we should (or can) use biomarkers to predict mild cognitive impairment or dementia, financial incentives to promote smoking cessation, the efficacy of HP eradication for functional dyspepsia, and results of the glycemic control arm of the GRADE Trial.
More shows like Primary Care Update
View all
JAMA Editors' Summary
135 Listeners
NEJM This Week
315 Listeners
JAMA Clinical Reviews
496 Listeners
AFP: American Family Physician Podcast
689 Listeners
Mayo Clinic Talks
278 Listeners
Frankly Speaking About Family Medicine
254 Listeners
The Curbsiders Internal Medicine Podcast
3,321 Listeners
JAMA Medical News
90 Listeners
Core IM | Internal Medicine Podcast
1,109 Listeners
Annals On Call Podcast
194 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
350 Listeners
Run the List
250 Listeners
The Curious Clinicians
366 Listeners
The Cribsiders
314 Listeners